<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03784157</url>
  </required_header>
  <id_info>
    <org_study_id>7222</org_study_id>
    <nct_id>NCT03784157</nct_id>
  </id_info>
  <brief_title>Study Of The Metabolic Parameters Of Uterine Muscle Cells</brief_title>
  <official_title>Study Of The Metabolic Parameters Of Uterine Muscle Cells In Cold Ischemia From Hysterectomies Programmed For Benign</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To date, no transplant has allowed pregnancy from a donor in a state of brain death. One of&#xD;
      the main reservations lies in the ischemic properties of the uterine graft between the&#xD;
      sampling time and the grafting time.&#xD;
&#xD;
      Investigators propose to carry out a prospective monocentric study at the University&#xD;
      Hospitals of Strasbourg in 2018/2019: the objective would be to study physiologically the&#xD;
      time of ischemia of the uterine muscle The objective is to carry out a preparatory study on&#xD;
      healthy uteri to study the ischemic properties of uterine muscle from living markers: study&#xD;
      of mitochondrial respiration and free radical production on uterine muscle samples If the&#xD;
      markers are reliable, they would then be used to measure the ischemia of whole uteri&#xD;
      collected at the end of the multi-organ retrieval process from donors in a state of brain&#xD;
      death and stored in tissue survival media.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 13, 2018</start_date>
  <completion_date type="Actual">December 13, 2020</completion_date>
  <primary_completion_date type="Actual">December 13, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Ischemia</measure>
    <time_frame>1 hour after sampling</time_frame>
    <description>Study physiologically the time of ischemia of the uterine muscle 1 hour after sampling</description>
  </primary_outcome>
  <enrollment type="Actual">20</enrollment>
  <condition>Ischemia</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patient benefiting from the routine management of a programmed hysterectomy by vaginal,&#xD;
        laparoscopic or laparotomy for benign pathologies&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  - Adult patient&#xD;
&#xD;
          -  Patient benefiting from the routine management of a programmed hysterectomy by&#xD;
             vaginal, laparoscopic or laparotomy for benign pathologies (fibroma, adenomyosis,&#xD;
             genital prolapse,...) within the CMCO&#xD;
&#xD;
          -  Patient consenting to the use of cells from her uterus for incineration for research&#xD;
             purposes&#xD;
&#xD;
          -  Patient giving her consent for the use of her medical data for the purposes of this&#xD;
             research.&#xD;
&#xD;
          -  Patient agreeing to participate in the study&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  - Patient refusing to participate in the study&#xD;
&#xD;
          -  Patient under the protection of justice&#xD;
&#xD;
          -  Patient under guardianship or curatorship&#xD;
&#xD;
          -  Suspicion of gynaecological malignant pathology&#xD;
&#xD;
          -  Pregnant or breastfeeding woman&#xD;
&#xD;
          -  Impossibility to give the subject informed information (difficulties in understanding&#xD;
             the subject...)&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Olivier GARBIN, MD</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital, Strasbourg, France</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Service de Gyn√©cologie - CMCO</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2018</verification_date>
  <study_first_submitted>December 13, 2018</study_first_submitted>
  <study_first_submitted_qc>December 20, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">December 21, 2018</study_first_posted>
  <last_update_submitted>February 15, 2021</last_update_submitted>
  <last_update_submitted_qc>February 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hysterotomy</keyword>
  <keyword>UTERINE MUSCLE CELLS</keyword>
  <keyword>ISCHEMIA</keyword>
  <keyword>COLD ISCHEMIA</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

